Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07664956 · ClinicalTrials.gov registry record · Phase 4
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
A Phase 4 study, sponsored by Christiana Care Health Services.
- Not yet
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT07664956 is a Phase 4 study that has not yet begun recruiting, run by Christiana Care Health Services. The registered enrollment target is 36 participants.
The verdict
NCT07664956, a Phase 4 study, has not yet begun recruiting, sponsored by Christiana Care Health Services.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
Interventions
- DRUG Cyclobenzaprine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07664956
The ClinicalTrials.gov registry entry for NCT07664956 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Christiana Care Health Services, which has 82 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cyclobenzaprine is the first listed.
NCT07664956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07664956 about?
NCT07664956 is a clinical study titled "Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy". Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
What is the current status of trial NCT07664956?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2026-07-01. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07664956?
The interventions under investigation include: Cyclobenzaprine (DRUG).
Who is sponsoring clinical trial NCT07664956?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.